Pharmacological blockade of NHE1 by NHE1-specific inhibitor HOE642 in combination with the chemotherapeutic drug temozolomide in mouse-derived glioma-associated microglia/myeloid cells significantly restored oxidative phosphorylation and reduced glycolysis [115]. The gene discussed is SLC9A1; the disease is central nervous system cancer.